Rapid AML Complete Molecular Testing
Precipio offers a new Rapid AML molecular testing service, delivering best in class turnaround time and clinically actionable results for your most critical AML patients.
Precipio offers a new Rapid AML molecular testing service, delivering best in class turnaround time and clinically actionable results for your most critical AML patients.
The NCCN AML guidelines state that results for actionable molecular abnormalities should be expedited with a maximum turnaround time of 3–5 days. With several targeted therapies now linked to specific mutations, having results in hand before induction decisions are made, is critical.
* From receipt of sample at Precipio’s clinical laboratory
** Technical specs can be found on our website at www.precipiodx.com/products
To set up for the Rapid AML Complete Molecular Testing Service and request patient sample collection kits, please contact us for more information.